A Global Enhanced Pharmacovigilance Pregnancy Surveillance Study of Pregnant Women Exposed to Yervoy® with 5-year Pediatric Follow-up (CA184-487) First published 19/05/2017 Last updated 23/03/2021 EU PAS number:EUPAS18596 Study Finalised